PolarCools signs two agreements in professional German ice hockey – ERC Ingolstadt and Straubing Tigers
The med-tech company PolarCool AB (publ.) continues its successful expansion of PolarCap® in European ice hockey, with the company signing two agreements in the German professional league DEL. ERC Ingolstadt and Straubing Tigers will both adopt treatment with the PolarCap® System into their concussion management routines.
PolarCool develops and markets the product PolarCap® System, which alleviates the effects of concussion. The primary users of PolarCap® System include sports clubs, organizations, and facilities in contact sports such as ice hockey, rugby, football, and handball, but also other sports with an increased risk of concussion.
PolarCool has previously established strategic collaborations in German ice hockey with professional clubs Adler Mannheim, Eisbären Berlin and Dresdner Eislöwen. With the addition of ERC Ingolstadt and Straubing Tigers, treatment with PolarCap® is now provided by five major German ice hockey clubs. The two clubs will use the PolarCap® for an initial evaluation period, with the option to continue into a two-year commercial agreement.
PolarCool CEO Erik Andersson comments:
-We view the development in German ice hockey very positively and I am pleased that yet two more ice hockey clubs have chosen to sign agreements for the use of PolarCap®. We foresee that the increased awareness of our treatment method provides opportunities for further agreements in this market.
The agreements with ERC Ingolstadt and Straubing Tigers reflects PolarCool's overall strategy to introduce PolarCap® System to the international ice hockey market and marks important strategic progress for PolarCool even if the financial impact of individual agreements is limited.
For more information
Erik Andersson – CEO PolarCool AB (publ.)
+46 - 738 60 57 00
E-mail: erik.andersson@polarcool.se
About PolarCool AB (publ.)
PolarCool AB (publ.) is a medical device company that develops, markets, and sells products for sports medicine. The company focuses on treatment of concussive and sub-concussive brain injury with the portable cooling device PolarCap® System. PolarCool AB (publ.) is based in Lund, Sweden, and its shares are listed on Spotlight Stock Market.